AI
4G Clinical raises $230M backed by Goldman Sachs to speed clinical drug trials
4G Clinical, a company that does drug supply ordering and randomization management for clinical trials, today announced that it has raised $230 million in a growth equity investment led by Goldman Sachs Asset Management.…